INMB (INmune Bio, Inc.) Short-Term Debt to Capital
INmune Bio, Inc. (INMB) specializes in Alzheimer's disease therapies, anticipating high margins through drug patenting. The team brings together leading immunologists who are granted autonomy and a profit share. This chart of current quotes on GURU.Markets shows a value of 0.04. However, the risk of a cash crunch and stringent FDA oversight create significant obstacles for pipeline development.
Analytical breakdowns for INmune Bio, Inc.
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
- company profitability and valuation multiples indicators:
Fundamental valuation:INmune Bio Corp
For the biotech startup INmune Bio, Inc. (INMB), which relies on grants and immunotherapy investments, minimizing immediate financial pressure is a critical stability factor. This ratio correlates liabilities with a maturity of up to one year against equity, allowing investors to assess bankruptcy risk or excessive management conservatism through the level of short-term debt to equity.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KalVista Pharmaceuticals Inc - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Septerna Pharma SEPN|Pieris Pharmaceuticals (PVLA) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio SVRA|Short-Term Debt to Equity Rigel Pharmaceuticals, Inc.|Short-Term Debt to Equity Ratio AnaptysBio Inc (ANAB)|Short-Term Debt to Equity Ratio ATXS (Astria Pharma)|Short-Term Debt to Capital enGene Corp (ENGN)|Short-Term Debt to Equity RAPT Therapeutics RAPT|JBIO: Short-Term Debt to Capital Ratio|Aclaris Therapeutics, Inc. - Short-Term Debt to Capital|Current Liabilities to Capital Kyverna Therapeutics Inc.|TLSA (Tiziana Life Sciences PLC) - Short-Term Debt to Equity Ratio|Cabaletta Bio Inc - Ratio of Short-Term Indebtedness to Capital|VTYX (Ventyx Biosciences) - Short-Term Debt to Capital|Short-Term Debt to Equity THTX|Short-Term Debt to Capital AVTX|Short-Term Debt to Capital Coefficient Eledon Pharmaceuticals Inc.|Short-Term Debt to Equity Agenus Inc AGEN|Climb Bio, Inc (CLYM) - Current Liabilities to Capital|ZURA: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital ATYR (atyrpharma.com)|ADAG: Short-Term Debt to Capital|IMA - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Shattuck Labs Inc|Short-Term Debt to Capital Ratio EQ (Equillium Bio)|Short-Term Debt to Capital CNTB|Short-Term Debt to Equity Ratio immunic-therapeutics.com IMUX|Atara Bio - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Coefficient InflaRx NV (IFRX)|X4 Pharma - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Adicet Bio ACET|celularity.com (CELU) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio BRNS|Short-Term Debt to Equity Kezar Life Sciences, Inc.|Short-Term Debt to Equity Ratio SAB Biotherapeutics Inc. (SABS)|Short-Term Debt to Capital AKTX|Short-Term Debt to Equity ENLV (enlivex.com)|Short-Term Debt to Equity Q32 Bio QTTB|GOVX (geovax.com) - Current Liabilities to Equity|Edesa Biotech - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital IBIO (iBio Inc)|CARM: Short-Term Debt to Capital|XTL Bio (XTLB) - Short-Term Debt to Capital|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|HCWB: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Aptevo Therapeutics (APVO)|Short-Term Debt to Equity Ratio aimimmuno.com AIM|Short-Term Debt to Capital ADTX (Aditxt, Inc.)|Short-Term Debt to Capital GRI Bio Corporation GRI|XRTX: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital HIND (reshapelifesciences.com)|REVB: Short-Term Debt to Capital|INDP - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Scinai|Short-Term Debt to Equity Ratio CalciMedica Corp (CALI)|Short-Term Debt to Equity Affimed (AFMD)|Short-Term Debt to Equity Ratio allakos.com ALLK|HOOKIPA Pharma - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital IGM Biosciences Inc. IGMS|ITOS - Short-Term Debt to Equity|OCEA (Ocean Biomedical Corp) - Short-Term Debt to Capital Ratio|TCBP: Short-Term Debt to Capital|Current Liabilities to Capital thirdharmonicbio.com (THRD)